These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10776410)

  • 1. Curosurf.
    Med Lett Drugs Ther; 2000 Mar; 42(1074):27-8. PubMed ID: 10776410
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neonatal respiratory distress syndrome treated with a natural surfactant. The Norwegian Curosurf study].
    Saugstad OD; Danielsen K; Grønn M; Holt J; Meberg A; Silberg IE; Okland O
    Tidsskr Nor Laegeforen; 1993 Aug; 113(19):2389-93. PubMed ID: 8378900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of Curosurf with premature infants--the prevention or treatment of the neonatal RDS].
    Iarŭkova N; Chernev T; Nikolov A
    Akush Ginekol (Sofiia); 1998; 37(3):12-4. PubMed ID: 10204257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant trials.
    Moya FR; Sinha SK; D'Agostino R
    Pediatrics; 2006 Jan; 117(1):245-7; author reply 247-8. PubMed ID: 16396889
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of severe respiratory distress syndrome with surfactant].
    Jacobsen T; Verder H; Skov L; Greisen GO; Friis-Hansen B
    Ugeskr Laeger; 1992 Jun; 154(23):1642-5. PubMed ID: 1631999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome.
    Dinger J; Töpfer A; Schaller P; Schwarze R
    Eur J Pediatr; 2002 Sep; 161(9):485-90. PubMed ID: 12200607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Saugstad OD
    Tidsskr Nor Laegeforen; 1994 Mar; 114(8):987-8. PubMed ID: 8191480
    [No Abstract]   [Full Text] [Related]  

  • 8. On "A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants" (Am J Perinatol 2004;21:109-120).
    Bancalari E
    Am J Perinatol; 2004 Jul; 21(5):307-9. PubMed ID: 15232767
    [No Abstract]   [Full Text] [Related]  

  • 9. [Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study].
    Verder H; Agertoft L; Albertsen P; Christensen NC; Curstedt T; Ebbesen F; Greisen G; Hobolth N; Holm V; Jacobsen T
    Ugeskr Laeger; 1992 Jul; 154(31):2136-9. PubMed ID: 1509593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants.
    Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR
    Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of exogenous surfactant on total respiratory system compliance.
    Milner AD; Vyas H; Hopkin IE
    Arch Dis Child; 1984 Apr; 59(4):369-71. PubMed ID: 6372707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A standardized in vivo model for determining the effectiveness of surfactant preparations].
    Oddoy A
    Z Erkr Atmungsorgane; 1991; 177(3):135-43. PubMed ID: 1808862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant substitution in ventilated very low birth weight infants: factors related to response types.
    Segerer H; Stevens P; Schadow B; Maier R; Kattner E; Schwarz H; Curstedt T; Robertson B; Obladen M
    Pediatr Res; 1991 Dec; 30(6):591-6. PubMed ID: 1805156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5 W's of surfactant for respiratory distress syndrome of the premature infant.
    Parmigiani S
    J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():25-7. PubMed ID: 15590430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up on infants treated with porcine surfactant replacement for severe neonatal and infant respiratory distress syndrome: antigenic reactivity evaluation.
    Marraro G; Foresti B; Casiraghi G; Monici Preti P
    Drugs Exp Clin Res; 1991; 17(10-11):511-5. PubMed ID: 1841041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of severe respiratory distress syndrome treated with a surfactant of porcine origin (curosurf)].
    Valls i Soler A; Román Echevarría L; Setién Aqueche G; López Heredia de Goya J
    An Esp Pediatr; 1990 Aug; 33(2):160-2. PubMed ID: 2275499
    [No Abstract]   [Full Text] [Related]  

  • 18. Pumactant and poractant alfa in respiratory distress syndrome.
    Wardhaugh AD; Matthes JW
    Lancet; 2000 Aug; 356(9231):765-6. PubMed ID: 11085711
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitamin A is systemically bioavailable after intratracheal administration with surfactant in an animal model of newborn respiratory distress.
    Singh AJ; Bronshtein V; Khashu M; Lee K; Potts JE; Friel J; Chessex P
    Pediatr Res; 2010 Jun; 67(6):619-23. PubMed ID: 20216104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective and curative effects of prophylactic administration of pulmonary surfactant on neonatal respiratory distress syndrome].
    Chu GL; Wang J; Xin Y; Zheng J; Zheng RX; Bi DZ
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):876-80. PubMed ID: 16759511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.